6-bromo-2-methoxy-1,8-naphthyridine, 95.0%, 250mg

1,3-Dioxolane, 2-(5-bromo-2,4-difluorophenyl)-, 98%, 10g

Methyl 5-oxopyrrolidine-3-carboxylate, 95.0%, 5g

2-(3,4-Dimethoxyphenyl)-N-hydroxyacetimidamide, 95.0%, 5g

D(-)-Mannitol, min 98%, Ph.Eur., USP, BP, for biochemistry, 250 g, plastic packaging.

tert-butyl 4-(4-((6-(2,4-dichlorophenyl)-8-ethyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)-2-fluorophenyl)piperazine-1-carboxylate, 98%, 50mg

(E)-3-(4-Fluoro-phenyl)-acryloyl chloride, 95.0%, 1g

1,2,4-Trichloro-3-iodobenzene, 98.0%, 25g

4-Fluoro-4'-(trans-4-propylcyclohexyl)biphenyl>98.0%(GC)1g

4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid, 97%, 50mg

tert-Butyl ((1-(hydroxymethyl)cyclopropyl)methyl)carbamate, 95.0%, 1g

2-(1-((Benzyloxy)carbonyl)azetidin-3-yl)acetic acid, 95.0%, 25g

tert-Butyl 2-bromo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate, 95.0%, 5g